Einloggen

Thematische Bibliographien / Buprenorphine patch

Inhaltsverzeichnis

Zeitschriftenartikel
Dissertationen

Auswahl der wissenschaftlichen Literatur zum Thema „Buprenorphine patch“

Autor: Grafiati

Veröffentlicht am 7. Juni 2025

Zuletzt aktualisiert am 2. August 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Buprenorphine patch" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Buprenorphine patch"

1

Kirpichnikov, A., M. Koto, and F. Ghoor. "Randomised controlled trial of intramuscular tramadol versus transdermal buprenorphine patch for early postoperative surgical pain." South African Journal of Surgery 60, no. 3 (2022): 160–66. http://dx.doi.org/10.17159/2078-5151/sajs3560.

Der volle Inhalt der Quelle

Annotation:

BACKGROUND: This study assesses the efficiency of the buprenorphine patch system compared to the routine use of tramadol intramuscular injections in the context of the South African public healthcare sector METHODS: Patients were randomised into two groups, who received routine tramadol injections 100 mg every 8 hours intramuscular and buprenorphine patches 5 mcg every hour. The study assessed the first 48 hours postoperatively. A visual discrete pain scale was used to assess the level of postoperative pain as well as all complications associated with insufficient analgesic administration RESU

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Steenhof, Naomi, John Flannery, and Joyce Lee. "Direct rotation from a fentanyl patch to a buprenorphine patch in a patient with chronic pain." Journal of Opioid Management 20, no. 3 (2024): 260–62. http://dx.doi.org/10.5055/jom.0865.

Der volle Inhalt der Quelle

Annotation:

Transitioning a patient with chronic pain from a fentanyl patch to a buprenorphine patch has not been well described in the literature. Even after a patient removes their fentanyl patch, the residual fentanyl in the skin continues to be absorbed for hours. Due to the risk of precipitated withdrawal when initiating buprenorphine, this transition is a more challenging opioid rotation to plan safely. We report a case of a patient who had been using a fentanyl patch for over 10 years and was successfully rotated directly to a buprenorphine patch.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Rekha K, Rekha K., Alan Anil, Anju Augustine, Dr Nithin G. Dr.Nithin G, and Anju Ts Anju Ts. "“Comparison of Safety and Efficacy of 5mg Buprenorphine Transdermal Patch and 50mg Tramadol Injection For Post Operative Pain Relief After Hemiarthroplasty In A Tertiary Care Hospital In South India”." International Journal of Pharmaceutical Research and Applications 09, no. 05 (2024): 311–18. https://doi.org/10.35629/4494-0905311318.

Der volle Inhalt der Quelle

Annotation:

OBJECTIVES:1. To compare safety and efficacy of 50mg intravenous tramadol and 5mg buprenorphine transdermal patch for postoperative pain relief after hemiarthroplasty 2.To identify side effects of injection tramadol and buprenorphine transdermal patch METHODS: A prospective observational study was directed on 72 patients during a study period of 6 months. Detailed literature review was conducted by using tertiary, secondary, primary resources. All the required study materials like informed consent document, patient information sheet and data entry form were designed. The study was conducted on

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

MECHCATIE, ELIZABETH. "Buprenorphine Patch Approved for Pain." Caring for the Ages 11, no. 9 (2010): 20. http://dx.doi.org/10.1016/s1526-4114(10)60241-7.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Colameco, MD, MEd, FASAM, Stephen, and Mel Pohl, MD, FASAM. "Review article. Buprenorphine in the workers' compensation setting." Journal of Opioid Management 10, no. 4 (2014): 277. http://dx.doi.org/10.5055/jom.2014.0215.

Der volle Inhalt der Quelle

Annotation:

Buprenorphine is approved by the Food and Drug Administration for the treatment of chronic pain in low-dose transdermal patch formulations and for the treatment of addiction in high-dose sublingual tablets and films. Clinicians often prescribe these high-dose preparations “off label” for pain management. In the workers' compensation setting, it is particularly important to consider factors such as a) if the injured person has, and is being treated for co-occurring addiction as well as pain; b) if alternative therapies, including opioid withdrawal, were considered prior to initiating buprenorph

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Jackson, Leanne K., Ivy O. Poon, Mary A. Garcia, Syed Imam, and Ursula K. Braun. "Buprenorphine Use for Analgesia in Palliative Care." Pharmacy 12, no. 3 (2024): 78. http://dx.doi.org/10.3390/pharmacy12030078.

Der volle Inhalt der Quelle

Annotation:

Buprenorphine is a semi-synthetic long-acting partial µ-opioid receptor (MOR) agonist that can be used for chronic pain as a sublingual tablet, transdermal patch (Butrans®), or a buccal film (Belbuca®). Buprenorphine’s unique high receptor binding affinity and slow dissociation at the MOR allow for effective analgesia while offering less adverse effects compared to a full agonist opioid, in particular, less concern for respiratory depression and constipation. It is underused in chronic pain and palliative care due to misconceptions and stigma from its use in opioid use disorder (OUD). This cas

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Acharya, Debibrata, Udit Panda, JPR Ravan, and Gaurav Chatterjee. "Transdermal Buprenorphine as a Short-Term Opioid Substitution Therapy Option: A Case Series." International Journal of Pharmaceutical and Clinical Research 16, no. 8 (2024): 1317–22. https://doi.org/10.5281/zenodo.13623588.

Der volle Inhalt der Quelle

Annotation:

<strong>Introduction:</strong> Globally an estimated 40.5 million people struggle with opioid use disorder. Opioid substitu-tion therapy [OST] with methadone or buprenorphine is the mainstay long-term management. Adverse effect such as sedation, constipation and sexual dysfunction lead to discontinuation of maintainance medications. Transdermal patch of buprenorphine obviates the need for daily dosing and may act as a short-term OST bridge while transitioning to other modalities. <strong>Methodology:</strong> A case series of three opioid dependent patients successfully treated

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Singh, Tanya, Reshma Jain, Rakesh Dangi, BP Shukla, and Nidhi Shrivastava. "Comparison of the Analagesic Efficacy of Transdermally Applied Buprenorphine and Ketoprofen for Postoperative Abdominal Pain in Dogs." Indian Journal of Veterinary Sciences & Biotechnology 19, no. 2 (2023): 74–77. http://dx.doi.org/10.48165/ijvsbt.19.2.14.

Der volle Inhalt der Quelle

Annotation:

Transdermal drug delivery (TDD) is defined as the non-invasive delivery of medications through the skin surface. The present study was planned to evaluate the efficacy of transdermal drug delivery system to alleviate the post-operative pain after abdominal surgery. Twelve clinical cases of dogs presented to the Department of Veterinary Surgery and Radiology, VCC, College of Veterinary Science and A.H., Mhow were selected for the study and divided into two groups. In group I (n=6) ketoprofen transdermal patch and in group II (n=6) buprenorphine transdermal patch was applied to the skin. The Gla

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Meena, Reema, Ashish Sharma, Namita Garg, and Ramgopal Yadav. "Comparison of Postoperative Analgesic Effect of Intravenous Tramadol versus Transdermal Buprenorphine Patch in Patients Undergoing Aortofemoral Graft Surgery." Indonesian Journal of Anesthesiology and Reanimation 7, no. 1 (2025): 22–29. https://doi.org/10.20473/ijar.v7i12025.22-29.

Der volle Inhalt der Quelle

Annotation:

Introduction: The popularity of the transdermal buprenorphine patch (TDB) is currently increasing for chronic pain management because of its ease of use, non-invasive nature, sustained drug delivery, and avoidance of side effects associated with oral or parenteral routes. However, its role in postoperative pain management for aortofemoral bypass surgery is poorly established. The study was designed to compare the postoperative analgesic effect of intravenous tramadol versus transdermal buprenorphine patch in patients undergoing aortofemoral graft surgery. Objective: To compare the efficacy bet

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Qutubuddin, Saifee Sakina, Sangeeta Bansal Agarwal, Deepshikha Parashar, Vijaya Laxmi Singh, and Garima Gupta. "Comparative evaluation of analgesic efficacy of buprenorphine transdermal patch and fentanyl transdermal patch in the management of postoperative pain after lower limb surgery." International Journal of Basic & Clinical Pharmacology 13, no. 6 (2024): 838–42. http://dx.doi.org/10.18203/2319-2003.ijbcp20243031.

Der volle Inhalt der Quelle

Annotation:

Background: Postoperative pain represents a significant medical issue that needs immediate attention. Despite advancements in pain management, managing postoperative pain remains challenging. Transdermal drug delivery systems (TDDS) offers a straightforward, reliable, non-invasive, and patient-friendly approach for alleviating post-surgical pain. Hence, this study was planned to evaluate the analgesic efficacy of buprenorphine and fentanyl transdermal patch in the management of post-operative pain after lower limb surgery. Methods: In this prospective, randomised study, 82 adult patients of ei

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Dissertationen zum Thema "Buprenorphine patch"

1

Schaaf, Thomas Martin. ""Patch-clamp"-Untersuchungen der Effekte von Alfentanil, Sufentanil und Remifentanil sowie Buprenorphin auf humane Serotonin3A-Rezeptoren /." Bonn, 2008. http://opac.nebis.ch/cgi-bin/showAbstract.pl?sys=000278362.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Culp, Jenna L. "Cocaine use, treatment retention and opioid abstinence at six months in a coordinated primary care and substance abuse treatment clinic among opioid-dependent patients treated with buprenorphine." Thesis, Boston University, 2012. https://hdl.handle.net/2144/12336.

Der volle Inhalt der Quelle

Annotation:

Thesis (M.A.)--Boston University<br>Cocaine use among opioid dependent persons is common, with an estimated 40 to 70% of those seeking treatment for opioid dependence, also using cocaine (Sullivan et al., 2011 ). The effects of cocaine use on treatment outcomes for those seeking medication assisted treatment (MAT) for opioid dependence are not well understood. Buprenorphine, prescribed under the brand name Suboxone, has recently emerged as a convenient, effective method of MAT. The Facilitated Access to Substance Abuse Treatment with Prevention And Treatment of HIV (FAST PATH) program at Bost

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Liao, Chang-Liang, and 廖昌亮. "Formulation Study of Buprenorphine Transdermal Patch." Thesis, 2008. http://ndltd.ncl.edu.tw/handle/45413987092210701435.

Der volle Inhalt der Quelle

Annotation:

博士<br>中國醫藥大學<br>藥物化學研究所<br>96<br>The purpose of this study was to develop the new transdermal formulation to improve the permeability of buprenorphine, increase the cumulative amount and reduce the loading dose of it. A rapid and sensitive stability indicating HPLC method has been developed and validated for the determination of buprenorphine (BPN) in transdermal patch. Chromatographic separation was achieved isocratically on an XBridgeTM Shield RP18 column with a mobile phase of acetonitrile / 0.06 M ammonium bicarbonate (58 / 42) (pH 9.5) at the flow rate of 1.5 mL/min with UV absorbance mon

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!